Healthcare - Press Releases

BEIJING, Feb. 2, 2025 /PRNewswire/ -- Wingderm once again participated in IMCAS World Congress from 30th January to 1st February 2025, presenting its core devices and newest platforms. The showcased devices included Lasermach Duo, Lasermach, Renuva, Mesoskin, and and other advanced solutions.

BEIJING, Feb. 2, 2025 /PRNewswire/ -- Wingderm once again participated in IMCAS World Congress from 30th January to 1st February 2025, presenting its core devices and newest platforms. The showcased devices included Lasermach Duo, Lasermach, Renuva, Mesoskin, and and other advanced solutions.

BEIJING, 2. Februar 2025 /PRNewswire/ -- Wingderm nahm erneut am IMCAS World Congress vom 30. Januar bis 1. Februar 2025 teil und prsentierte seine wichtigsten Gerte und neuesten Plattformen. Zu den vorgestellten Gerten gehrten Lasermach Duo, Lasermach, Renuva, Mesoskin und andere fortschrittliche Lsungen.

BEIJING, 2 fvrier 2025 /PRNewswire/ -- Wingderm a de nouveau particip au congrs mondial IMCAS du 30 janvier au 1er fvrier 2025, prsentant ses principaux appareils et ses nouvelles plateformes. Les appareils prsents comprenaient Lasermach Duo, Lasermach, Renuva, Mesoskin et d'autres solutions avances.

NEW YORK, Feb. 2, 2025 /PRNewswire/ --Report on how AI is driving market transformation - The globalclimbing gym market size is estimated to grow by USD 7.72 billion from 2025-2029, according to Technavio. The market is estimated to grow at a CAGR of 17.2% during the forecast period. Increasing popularity of outdoor sportsis driving market growth,with a trend towardsinclusion of climbing events in olympics. However,lack of awareness and market penetration in developing countries poses a challenge. Key market players include BoulderBox, Boulderklub Kreuzberg GmbH, Brooklyn Boulders LLC, CityROCK, Climb Craft Ltd., Climb So iLL, Climbing Centre Group Ltd., Glasgow Climbing Centre, High Point, Latitude Climbing LLC, Momentum Indoor Climbing, Movement, Rock Aliens, Sender One Climbing LLC, Sputnik Climbing SL, The Castle Climbing Centre, The Cliffs, The Gravity Vault Indoor Rock Gyms, Vertical Endeavors, and Vertical World Inc..

NEW YORK, Jan. 31, 2025 /PRNewswire/ -- Report with market evolution powered by AI - The globalhigh throughput screening (HTS) marketsize is estimated to grow by USD 19.9 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of almost12.12% during the forecast period. Rise in R and D investmentsis driving market growth,with a trend towardsincreasing focus on promotional activities. However,shortage of trained healthcare professionals poses a challenge. Key market players include Agilent Technologies Inc., Aurora Biomed Inc., Axxam Spa, Beckman Coulter Inc., Bio Rad Laboratories Inc., Biomat Srl, BMG LABTECH GmbH, Charles River Laboratories International Inc., Corning Inc., Danaher Corp., DIANA Biotechnologies s.r.o, HighRes Biosolutions, JSR Life Sciences LLC, Lonza Group Ltd., Merck KGaA, NanoTemper Technologies GmbH, PerkinElmer Inc., Sygnature Discovery Ltd., Tecan Trading AG, and Thermo Fisher Scientific Inc..

PHOENIX, Jan. 30, 2025 /PRNewswire/ -- Prominently featured in The Inner Circle,Rimah A. Sharief, MD, FAAP, is acknowledged as a Pinnacle Lifetime Member for her contributions to Pediatric Endocrinology.

CANTON, Ohio, Jan. 30, 2025 /PRNewswire/ -- The nation's most-comprehensive healthsharing ministry got its start 30 years ago this month when a group of five families held the first service of their new church, the Gospel Light Mennonite Church in rural Virginia.

Conference Call and Webcast Scheduled for Thursday, February 6

ST. PAUL, Minn., Jan. 30, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) will release its fourth quarter fiscal year 2024 financial results on Thursday, February 27, 2025, after the U.S. financial markets close. Following the release, Solventum management will host a webcast to discuss the results and fiscal year 2025 outlook. Other forward-looking and material information may also be discussed during the webcast.

BURLINGTON, Mass., Jan. 30, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Dipal Doshi, Chief Executive Officer of Entrada Therapeutics (NASDAQ: TRDA) and a recognized leader in the biotechnology and pharmaceutical industries, has been elected to its Board of Directors at its Annual Meeting of Stockholders held earlier today. Mr. Doshi was nominated for election by the Board, together with nine returning directors, in December 2024.

WASHINGTON, Jan. 30, 2025 /PRNewswire/ --Paralyzed Veterans of AmericaChief Executive Officer Carl Blake releases statement following remarks made by President Donald Trump at a press conference addressing yesterday's tragic crash of American Airlines Flight 5342 and an Army Blackhawk helicopter.

SECAUCUS, N.J., Jan. 30, 2025 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced that it has been selected as one of the 2025 World's Most Admired Companies by Fortune magazine, the 11th consecutive year the company has been named to the elite list of globally respected companies.

TORONTO and DALLAS, Jan. 30, 2025 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, today announced that Bristol Investor Relations will host an investor webcast Thursday, February 6, 2025 at 2:00 PM ET.

AUSTIN, Texas, Jan. 30, 2025 /PRNewswire/ -- Dr. RogerHollis from the University of California, Los Angeles, project scientist from the laboratory of Dr. Donald Kohn, a world leader in developing gene replacement therapies using blood stem cells, has been awarded a $5.8 million translational research award from the California Institute for Regenerative Medicine (CIRM) to further support the development of a hematopoietic stem cell gene therapy (HSC-GT) to treat Angelman syndrome (AS).

LOS ANGELES, Jan. 30, 2025 /PRNewswire/ --The DJS Law Groupannounces that it is investigating claims on behalf of investors ofCARGO Therapeutics, Inc. ("CARGO" or "the Company") (NASDAQ: CRGX) for violations of the securities laws.

MOBILE, Ala., Jan. 30, 2025 /PRNewswire/ -- AltaPointe Health, a leading provider of behavioral health services in the Mobile community, has reached a significant milestone in its mission to support mental health and crisis intervention. Since opening its Behavioral Health Crisis Center in May 2021, the facility has saved the community more than$50 millionin associated costs.

Restore Hyper Wellness Expands Skin Health Offerings with 4 Facials, 4 Chemical Peels, and Retail Home Care Solutions from Jan Marini Skin Research

BLINCYTO, ,

The MASH treatment landscape is evolving rapidly, driven by a diverse array of therapeutic classes, each with unique mechanisms and potential impacts. The forecast period reveals significant shifts and emerging trends that will shape future market dynamics.

CHICAGO, Jan. 30, 2025 /PRNewswire/ -- The National Association for Healthcare Quality(NAHQ) has announced its 2025 board members and has acknowledged those in leadership positions.Patricia Resnik, MJ, MBA, RRT, FACHE, CPHQ, CHC, CHPC, remains in the role of its 2025 president; Nidia Williams, PhD, MBB, CPHQ, FNAHQ, serves as immediate past president; April M. Taylor, MS, MHA, FACHE, CMQ/OE, CLSSBB, CPHQ, CPPS, is president-elect; andCathy Duquette, PhD, MBA, RN, NEA-BC, CPHQ, FNAHQ, is secretary/treasurer.

BLINCYTOwurde zustzlich zu einer mehrphasigen konsolidierenden Chemotherapie eingesetzt und senkte das Sterberisiko im Vergleich zu einer Chemotherapie allein erheblich

First Drug Approved in New Class of Non-Opioid Pain Medicines; Agency Continues to Take Steps to Support New Approaches for Pain Management

JERSEY CITY, N.J., Jan. 30, 2025 /PRNewswire/ -- Celltrion today announced that the U.S. Food and Drug Administration (FDA) has approved AVTOZMA (CT-P47, tocilizumab-anoh) in both an intravenous (IV) and subcutaneous (SC) formulation as a biosimilar to ACTEMRA. AVTOZMA is indicated for the treatment of multiple diseases including rheumatoid arthritis (RA), giant cell arteritis (GCA), polyarticular juvenile idiopathic arthritis (pJIA), systemic juvenile idiopathic arthritis (sJIA) and coronavirus disease (COVID-19).[1]

NEW YORK, Jan. 30, 2025 /PRNewswire/ -- Report with the AI impact on market trends - The global genomics marketsize is estimated to grow by USD 5.21 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of over3.16% during the forecast period. Rising investments in genomics research and developmentis driving market growth,with a trend towardsadvances in sequencing technologies. However,varying regulations in genomics research and testing poses a challenge. Key market players include 10X Genomics Inc., Abcam plc, Agilent Technologies Inc., Becton Dickinson and Co., BGI Group, Bio Rad Laboratories Inc., Danaher Corp., Eppendorf SE, F. Hoffmann La Roche Ltd., Hamilton Bonaduz AG, Illumina Inc., Myriad Genetics Inc., New England Biolabs Inc., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., Promega Corp., QIAGEN NV, Standard BioTools Inc., Thermo Fisher Scientific Inc., and PerkinElmer Inc.